Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brian I Rini

Showing results (71-80 of 401) with videos related to

Pageof 41
Sort By:
BJU International|April 20, 2007
Immunotherapy for metastatic renal cell carcinomaDavid F McDermott, Brian I Rini
Current Opinion in Urology|August 2, 2008
Targeted therapy in renal cell carcinomaBhanu K Vakkalanka, Brian I Rini
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 25, 2016
Pharmacokinetically Guided Dosing of Oral Drugs: True Precision Oncology?Moshe C Ornstein, Brian I Rini
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 20, 2016
Future Challenges for Drug Development in Renal Cell CarcinomaBrian I Rini, Nicholas J Vogelzang
Current Oncology Reports|March 5, 2022
Approaches to First-Line Therapy for Metastatic Clear Cell Renal Cell CarcinomaYu-Wei Chen, Brian I Rini
Therapeutic Advances in Medical Oncology|July 4, 2012
Novel agents in renal carcinoma: a reality checkYana G Najjar, Brian I Rini
Clinical Genitourinary Cancer|June 8, 2007
What is standard initial systemic therapy in metastatic renal cell carcinoma?Brian I Rini, David McDermott, Michael Atkins
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 16, 2022
Reply to S. Tan et alBrian I Rini, Javid J Moslehi, Subramanian Hariharan
Oncology (Williston Park, N.Y.)|September 23, 2011
Malignant angiomyolipoma: a rare entity with unusual biologyBrian I Rini, Steven C Campbell, Ming Zhou
Urology|December 6, 2017
Organ Preservation for Recurrent Urethral Adenocarcinoma With Concurrent Chemotherapy and RadiationPrateek Mendiratta, Brian I Rini, Rahul D Tendulkar
Pageof 41

Showing results (71-80 of 401) with videos related to

Sort By:
Pageof 41
BJU International|April 20, 2007
Immunotherapy for metastatic renal cell carcinomaDavid F McDermott, Brian I Rini
Current Opinion in Urology|August 2, 2008
Targeted therapy in renal cell carcinomaBhanu K Vakkalanka, Brian I Rini
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 25, 2016
Pharmacokinetically Guided Dosing of Oral Drugs: True Precision Oncology?Moshe C Ornstein, Brian I Rini
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 20, 2016
Future Challenges for Drug Development in Renal Cell CarcinomaBrian I Rini, Nicholas J Vogelzang
Current Oncology Reports|March 5, 2022
Approaches to First-Line Therapy for Metastatic Clear Cell Renal Cell CarcinomaYu-Wei Chen, Brian I Rini
Therapeutic Advances in Medical Oncology|July 4, 2012
Novel agents in renal carcinoma: a reality checkYana G Najjar, Brian I Rini
Clinical Genitourinary Cancer|June 8, 2007
What is standard initial systemic therapy in metastatic renal cell carcinoma?Brian I Rini, David McDermott, Michael Atkins
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 16, 2022
Reply to S. Tan et alBrian I Rini, Javid J Moslehi, Subramanian Hariharan
Oncology (Williston Park, N.Y.)|September 23, 2011
Malignant angiomyolipoma: a rare entity with unusual biologyBrian I Rini, Steven C Campbell, Ming Zhou
Urology|December 6, 2017
Organ Preservation for Recurrent Urethral Adenocarcinoma With Concurrent Chemotherapy and RadiationPrateek Mendiratta, Brian I Rini, Rahul D Tendulkar
Pageof 41